Company news

Aurora Cannabis Inc. news in 2024

Aurora Cannabis Inc.'s news releases, calls and decks from 2024, newest first.

View company

Aurora Announces Distribution Partnership Between MedReleaf Australia and The Entourage Effect

December 17, 2024

Aurora Announces Medical Product Advancements from Leading Cannabis Research Facility

November 26, 2024

Aurora Cannabis Expands Innovative Recreational Product Portfolio

November 20, 2024

Aurora Cannabis Announces Fiscal 2025 Second Quarter Results

November 6, 2024

Aurora Cannabis to Host Second Quarter 2025 Investor Conference Call

October 24, 2024

Aurora Introduces Innovative Cannabis Oil Range to Meet Diverse Patient Needs in Australia

October 16, 2024

Aurora Cannabis Announces Collaboration on Genome BC-Funded Project Addressing Distinct Cannabis Aromas

October 2, 2024

Aurora CEO Miguel Martin takes on additional role as Executive Chairman of Board of Directors

September 20, 2024

Aurora Cannabis Advances Auto-Flowering Research, Unveiling Key Insights for Future Cultivation Excellence

September 17, 2024

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce launch of novel Luo CBD lozenge

September 9, 2024

Aurora Cannabis Announces Results of 2024 Annual General and Special Meeting

August 12, 2024

Aurora Cannabis Announces Fiscal 2025 First Quarter Results and Delivers Positive Free Cash Flow

August 7, 2024

Aurora Cannabis and Vectura Fertin Pharma, Inc. announce commercial collaboration

August 1, 2024

Aurora Cannabis Inc. Reminds Shareholders to Vote in Advance of the Proxy Voting Deadline for its 2024 Annual General and Special Meeting of Shareholders

July 30, 2024

Aurora Cannabis to Host First Quarter 2025 Investor Conference Call

July 29, 2024

Aurora Receives Expanded Cultivation and Unique Research Licenses for German Facility

July 25, 2024

Aurora Cannabis Inc. Announces Filing and Mailing of Management Information Circular in Connection with Upcoming Annual General and Special Meeting of Shareholders

July 9, 2024

Aurora Cannabis Files Full Year Results and Announces Fiscal 2024 Fourth Quarter

June 20, 2024

Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2024 Investor Conference Call and File Related Year End Information

June 7, 2024

Aurora Unveils Premium Resin Cartridges in Australia

June 5, 2024

Aurora Cannabis Announces Appointment of New Director

May 15, 2024

Aurora Marks First Shipment of Medical Cannabis to the New Zealand Market

May 8, 2024

Aurora Improves Offerings in Australia with New Range of Premium Dried Flower Products

April 30, 2024

Aurora Cannabis Commends Germany's Landmark Legalization Achievement

April 1, 2024

Aurora Cannabis Achieves Australia's TGA GMP Certification, Setting Global Standard for Quality and Compliance

March 20, 2024

Aurora Introduces Medical Cannabis Pastilles for Patient Relief in Australia

March 4, 2024

Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]

February 29, 2024

Aurora Partners with Script Assist to Provide Better Access to UK Medical Cannabis

February 28, 2024

Aurora Cannabis Announces CFO Transition and Completion of Previously Announced Share Consolidation

February 20, 2024

Aurora Cannabis Announces Fiscal 2024 Third Quarter Results; Generates Record Adjusted EBITDA of $4.3 Million

February 8, 2024

Aurora Cannabis Acquires MedReleaf Australia

February 8, 2024

Aurora Cannabis Provides Business Update and Announces Date of Third Quarter Fiscal Year 2024 Investor Conference Call

January 31, 2024

Aurora Unveils Innovative Cannabis-Infused Ready-to-Drink Beverage in Latest Medical Product Launch

January 24, 2024

Calls in 2024

Decks in 2024